ClinicalTrials.gov
ClinicalTrials.gov Menu

A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01036048
Recruitment Status : Completed
First Posted : December 21, 2009
Last Update Posted : December 21, 2009
Sponsor:
Information provided by:
Catholic University of the Sacred Heart

Brief Summary:
A meta-analysis to compare outcomes of drug eluting stents (DES) versus bare metal stent (BMS) in saphenous vein graft (SVG) disease.

Condition or disease Intervention/treatment
Saphenous Vein Graft Disease Device: drug eluting stent Device: bare metal stent

Detailed Description:
To compare outcomes (death, myocardial infarction, target vessel revascularization) of drug eluting stent versus bare metal stent in saphenous vein graft disease.

Study Type : Observational
Actual Enrollment : 5806 participants
Time Perspective: Retrospective
Official Title: Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease: Insights From a Meta-analysis
Study Start Date : May 2009
Actual Primary Completion Date : December 2009
Actual Study Completion Date : December 2009

Group/Cohort Intervention/treatment
cabg disease
pts with saphenous vein graft disease
Device: drug eluting stent
pts with cabg disease treated with drug eluting stent
Other Name: des
Device: bare metal stent
pts with cabg disease treated with bare metal stent
Other Name: bms



Primary Outcome Measures :
  1. death [ Time Frame: years depending from studies retrieved ]

Secondary Outcome Measures :
  1. myocardial infarction [ Time Frame: years depending from study retrieved ]
  2. target vessel revascularization [ Time Frame: years depending from study retrieved ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with CABG disease
Criteria

Inclusion Criteria:

  • CABG disease
  • randomized studies
  • not randomized studies

Exclusion Criteria:

  • studies reporting composite and not single endpoints, duplicate reporting

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01036048


Sponsors and Collaborators
Catholic University of the Sacred Heart
Investigators
Principal Investigator: ALESSANDRO LUPI, MD OSPEDALE MAGGIORE NOVARA
Principal Investigator: ELIANO NAVARESE, MD CATHOLIC UNIVERSITY OF SACRED HEART

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: navarese, Catholic University of the Sacred Heart
ClinicalTrials.gov Identifier: NCT01036048     History of Changes
Other Study ID Numbers: N28LBCF80-07
First Posted: December 21, 2009    Key Record Dates
Last Update Posted: December 21, 2009
Last Verified: December 2009

Keywords provided by Catholic University of the Sacred Heart:
saphenous vein graft
stent